David M. Reese - May 7, 2024 Form 4 Insider Report for AMGEN INC (AMGN)

Role
EVP & Chief Technology Officer
Signature
/s/ David M. Reese
Stock symbol
AMGN
Transactions as of
May 7, 2024
Transactions value $
$6,236,330
Form type
4
Date filed
5/9/2024, 07:07 PM
Previous filing
May 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Award $0 +3.2K +5.45% $0.00 61.9K May 7, 2024 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMGN Nqso (Right to Buy) Award $6.24M +20.8K $300.30 20.8K May 7, 2024 Common Stock 20.8K $300.30 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.
F2 These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,363 RSUs which will vest on 4/30/2025; 2,611 RSUs which will vest in installments of 1,286 on 5/2/2025, 1,325 on 5/2/2026; 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027; and 3,196 RSUs which will vest in installments of 1,054 on 5/7/2026, 1,055 on 5/7/2027, and 1,087 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3 These shares include 449 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F4 These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.